Increased incidence of cytomegalovirus disease after autologous CD34- selected peripheral blood stem cell transplantation

Blood

Volumn 94, Issue 12, 1999, Pages 4029-4035

  Holmberg, Leona A ^a,b   Boeckh, Michael ^a   Hooper, Heather ^a   Leisenring, Wendy ^a   Rowley, Scott ^a   Heimfeld, Shelly ^a   Press, Oliver ^a   Maloney, David G ^a   McSweeney, Peter ^a   Corey, Lawrence ^a   Maziarz, Richard T ^a   Appelbaum, Frederick R ^a   Bensinger, William ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; BLOOD DISEASE; CELL POPULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LYMPHOMA; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

EID: 13044276241     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.4029     Document Type: Article

References (42)

1. Harousseau J-L, Attal M, Divine M, Marit G, Leblond V, Stoppa A-M, Bourhis J-H, Caillot D, Boasson M, Abgrall J-F, Facon T, Linassier C, Cahn J-Y, Lamy T, Troussard X, Gratecos N, Pignon B, Auzanneau G, Sugita K: Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the French Registry on autologous transplantation in multiple myeloma. Blood 85:3077, 1995
2. Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL Jr, Saez R, Spitzer G, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM: High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 15:1870, 1997
3. Brunvand MW, Bensinger WI, Soll E, Weaver CH, Rowley SD, Appelbaum FR, Lilleby K, Clift RA, Gooley TA, Press OW, Fefer A, Storb R, Sanders JE, Martin PL, Chauncey T, Maziarz RT, Zuckerman N, Montgomery P, Dorn R, Weiden PL, Demirer T, Holmberg LA, Schiffman K, McSweeney PA, Buckner CD: High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: Comparison of autologous bone marrow and peripheral blood stem cells. Bone Marrow Transplant 18:131, 1996
4. Gertz, MA, Witzig TE, Pineda AA, Greipp P, Kyle RA, Litzow MR: Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplant. Bone Marrow Transplant 19:337, 1997
5. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN: Gene-marking to trace the origin of relapse after autologous bone marrow transplantation. Lancet 341:85, 1993
6. Abonour R, Scott KM, Kunkel LA, Robertson MJ, Hromas R, Graves V, Lazaridis EN, Cripe L, Gharpure V, Traycoff CM, Mills B, Srour EF, Cornetta K: Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma. Bone Marrow Transplant 22:957, 1998
7. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995
8. + cells to remove circulating tumor cells. Blood 87:1625, 1996
9. Mahe B, Milpied N, Hermouet S, Robillard N, Moreau P, Letortorec S, Rapp MJ, Bataille R, Harousseau JL: G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma. Br J Haematol 92:263, 1996
10. Shpall EJ, LeMaistre CF, Holland K, Ball E, Jones RB, Saral R, Jacobs C, Heimfeld S, Berenson R, Champlin R: A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood 90:4313, 1997
11. Nachbaur D, Fink FM, Nussbaumer W, Gachter A, Kropshofer G, Ludesher C, Niederwieser D: CD34+ selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-center experience. Bone Marrow Transplant 20:827, 1997
12. McQuaker IG, Haynes AP, Anderson S, Stainer C, Owne RG, Morgan GJ, Lumley M, Milligan D, Fletcher J, Bessell EM, Davis JM, Russell NH: Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: A pilot study. J Clin Oncol 15:2288, 1997
13. + selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood 93:1858, 1999
14. Bacigalupo A, Mordini N, Pitto A, Piaggio G, Podesta M, Benvenuto F, van Lint MT, Valbonesi M, Lercari G, Carlier P, Lamparelli T, Gualandi F, Occhini D, Bregante S, Figari O, Soracco M, Vassallo F, DeStefano G: Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: Severe immunodeficiency and related complications. Br J Haematol 98:760, 1997
15. Matsuda Y, Hara J, Osugi Y, Fujisaki H, Takai K, Ohta H, Nakanishi K, Tokimasa S, Miyoshi H, Tanaka-Taya K, Yamanishi K, Okada S: Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA-mismatched donors. Bone Marrow Transplant 21:355, 1998
16. Link H, Arseniev L, Ljungman P: Final results of cytomegalovirus infections after allogeneic peripheral blood progenitor cell transplantation: An EBMT Survey. Blood 92:281, 1998
17. Miyamoto T, Gondo H, Miyoshi Y, Shigematsu H, Minematsu T, Takenaka K, Tanimoto K, Horiuchi T, Asano Y, Inaba S, Minamishima Y, Niho Y: Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 100:348, 1998
18. Sica S, Salutari P, Orto La Barbera E, Sora F, Piccirillo N, Leone G: Infectious complications after CD34-selected autologous peripheral blood stem cell transplantation. Br J Haematol 101:592, 1998
19. Peniket AJ, Perry AR, Williams CD, MacMillan A, Watts MJ, Issacson PG, Goldstine AH, Linck DC: A case of EBV-associated lymphoproliterative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 22:307, 1998
20. Nachbaur D, Kropshofer G, Feichtinger H, Allerberger F, Niederwieser Dj: Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin, and recombinant human interleukin-2. Bone Marrow Transplant 19:1261, 1997
21. Boeckh M, Boivin G: Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clin Microbiol Rev 11:533, 1998
22. Boeckh M, Bowden RA: Cytomegalovirus infection in marrow transplantation, in Buckner CD, Clift RA (eds): Technical and Biological Components of Marrow Transplantation. Boston, MA, Kluwer Academic, 1995, p 97
23. Ljungman P: Immune reconstitution and viral infections after stem cell transplantation. Bone Marrow Transplant 21:572, 1998
24. Wingard JR, Chen DY, Burns WH, Fuller DJ, Braine HG, Yeager AM, Kaiser H, Burke PJ, Graham ML, Santos GW, Saral R: Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 71:1432, 1988
25. Wingard JR, Sostrin MB, Vriesendorp HM, Mellits ED, Santos GW, Fuller DJ, Braine HG, Yeager AM, Burns WH, Saral R: Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 46:61, 1988
26. Ljungman P, Biron P, Bosi A, Chan JY, Goldstone AH, Gorin NC, Link H, Messina C, Michallet M, Richard C, Verdonck L: Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Infectious Disease Working Party of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 13:209, 1994
27. Sakuma H, Hosoya M, Kanno H, Kikuta A, Konno K, Kawano Y, Takaye Y, Shigeta S, Suzuki H: Risk of cytomegalovirus infection after peripheral blood stem cell transplantation. Bone Marrow Transplant 19:49, 1997
28. Boeckh M, Steven-Ayers T, Bowden RA: Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation. Infect Dis 174:907, 1996
29. Rowley SD, Bensinger WI, Gooly TA, Buckner CD: The effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 83:2731, 1994
30. Rowley SD, Loken M, Radich J, Kunkle LA, Mills BJ, Gooley T, Holmberg L, McSweeney P, Beach K, MacLeod B, Appelbaum F, Bensinger WI: Isolation of CD34+cells from blood stem cell components using the Baxter Isolex system. Bone Marrow Transplant 21:1253, 1998
31. Boeckh M, Gooley TA, Myerson D, Cunningham T: Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study. Blood 88:4063, 1996
32. Prentice RL, Kalhfleisch JD: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
33. Rothman KJ: Modern Epidemiology. Boston, MA, Little, Brown, 1986
34. Cleaves CA, Reed EC, Hackman RC, Myers JD: Rapid diagnosis of invasive Cytomegalovirus infection by examination of tissue specimens in centrifugation culture. Am J Clin Pathol 88:354, 1987
35. Lemoli RM, Fortuna A, Raspadori D, Ventura MA, Martinelli G, Gozzetti A, Leopardi G, Ratta M, Caro M, Tura S: Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma. Leuk Lymphoma 26:1, 1997 (suppl 1)
36. + hematopoietic progenitors. Blood 91:2588, 1998
37. Reusser P, Attenhofer R, Hebart H, Helg C, Chapuis B, Einsele H: Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood 89:3873, 1997
38. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
39. Boeckh M, Bowden RA, Goodrich JM, Pettigner M, Meyers JD: Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 80:1358, 1992
40. Hebart H, Schroder A, Loffler J, Klingebiel T, Martin H, Wassmann B, Gerneth F, Rabenaw H, Jahn G, Kanz L, Muller CA, Einsele H: Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation. J Infect Dis 175:1490, 1997
41. Boeckh M, Bowden RA, Gooley T, Myerson D, Corey L: Successful modificiation of a pp65 antigenemia-based early treatment strategy for prevention of Cytomegalovirus disease in allogeneic marrow transpant recipients. Blood 93:1781, 1999 (letter)
42. Limaye AP, Stensland L, Ryncarz A, Corey L, Boeckh M: CMV DNA load in plasma for the diagnosis of CMV disease before engraftment after marrow transplantation. Clin Infect Dis 27:931, 1998 (abstr 61)